Jeffrey A. Cohen

机构：Cleveland Clinic

发表论文 68 篇 · 总被引 4978 次 · h-index 20

代表论文

• Ofatumumab versus Teriflunomide in Multiple Sclerosis (2020 · New England Journal of Medicine · 被引 733)
• Alemtuzumab CARE-MS II 5-year follow-up (2017 · Neurology · 被引 280)
• Alemtuzumab CARE-MS I 5-year follow-up (2017 · Neurology · 被引 224)
• A randomized placebo-controlled phase III trial of oral laquinimod for multiple sclerosis (2014 · Journal of Neurology · 被引 197)
• The EDSS-Plus, an improved endpoint for disability progression in secondary progressive multiple sclerosis (2016 · Multiple Sclerosis Journal · 被引 148)
• Infection risk with alemtuzumab decreases over time: pooled analysis of 6-year data from the CAMMS223, CARE-MS I, and CARE-MS II studies and the CAMMS03409 extension study (2018 · Multiple Sclerosis Journal · 被引 71)